Cerus in the News

November 21, 2016
East Bay Economic Development Alliance - Cerus Selected as an East Bay Innovation Awards Finalist for Life Sciences 

 

September 12, 2016
San Francisco Business Times - How this East Bay company is helping squash Zika

 

September 5, 2016
Chemical & Engineering News -  Zika is boon to device makers; Blood tests and purification methods ramp up as FDA recommends U.S.-wide screening

August 26, 2016
Wired - Testing for Zika Isn't the Only Way to Keep the Blood Supply Safe

 

July 28, 2016
Reuters - FDA takes steps to protect blood supply in Florida amid Zika probe

 

July 20, 2016
NBC Bay Area -  Concord Biotech Company Cerus Donates Blood Sterilization Tech to Rio Ahead of Olympic Games

 

July 19, 2016
Fox Illinois - Zika Virus Safety Concerns for the Blood Supply
 

July 19, 2016
ABC Channel 7 News San Francisco -  Blood Donation Centers Make Plea for Donors Among Nationwide Shortage

July 14, 2016
San Francisco Chronicle - Concord's Cerus Helps Ensure Blood Safety for Rio Olympics 

 

June 20, 2016
FierceMedical Devices - Cerus snags up to $180M from BARDA for blood pathogen reduction system

 

February 11, 2016
Wired – The U.S. Has the Tech to Keep Zika Out of the Blood Supply

 

September 28, 2015
The Wall Street Journal - The Rising Risk of a Contaminated Blood Supply; Amid new pathogens and cost pressures, efforts are under way to keep patients safe

 

June 16, 2015
Scientific American – The INTERCEPT Blood System Rids Blood Donations of All Pathogens

 

June 11, 2015
Science News for Students – A Germ Stopper for Blood Products


May 29, 2015
Transfusion News – Implementation of Pathogen Reduction in the United States (VIDEO)


March 24, 2015
FORBES – A Bug Zapper for Blood: Intercept System Deactivates Pathogens in Donated Plasma


January 26, 2015
Med Device Online CEO Corner: Interview with Obi Greenman, President & CEO of Cerus –
Development of a Pathogen Inactivation System to Stop Ebola and Other Deadly Outbreaks


December 17, 2014
Hematology Times – FDA Approves Pathogen Inactivation System for Plasma

 

Any links to third party Web pages from this Web site are provided for your convenience only. Cerus does not monitor, author, edit, or endorse any information provided in these third party pages and assumes no responsibility for the accuracy of their content.

  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000
  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600